Gadolinium

• 

  Subject Areas on Research

  • 196 High-Resolution Magnetic Resonance Imaging in Trigeminal Neuralgia: Added Benefit of Contrast Enhanced Constructive Interference in Steady State Imaging. 
  • A magnetization-driven gradient echo pulse sequence for the study of myocardial perfusion. 
  • A structural basis for lithium and substrate binding of an inositide phosphatase. 
  • Abdominopelvic and lower extremity deep venous thrombosis: evaluation with contrast-enhanced MR venography with a blood-pool agent. 
  • Accuracy of Cardiac Magnetic Resonance Imaging in Diagnosing Pediatric Cardiac Masses: A Multicenter Study. 
  • Age-related changes in eye morphology and aqueous humor dynamics in DBA/2J mice using contrast-enhanced ocular MRI. 
  • Agreement among RTOG sarcoma radiation oncologists in contouring suspicious peritumoral edema for preoperative radiation therapy of soft tissue sarcoma of the extremity. 
  • Altered Nulling of Myocardium and Blood Pool. 
  • Aluminum is a weak agonist for the calcium-sensing receptor. 
  • Aluminum-induced DNA synthesis in osteoblasts: mediation by a G-protein coupled cation sensing mechanism. 
  • Anatomic and clinical correlates of septal morphology in hypertrophic cardiomyopathy. 
  • Anatomic compression caused by high-volume convection-enhanced delivery to the brain. 
  • Automatic motion correction for breast MR imaging. 
  • Cardiac MRI for Detection of Cardiac Sarcoidosis. 
  • Characterization of N-ethyl-N-nitrosourea-induced malignant and benign breast tumors in rats by using three MR contrast agents. 
  • Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases. 
  • Contrast enhanced liver MRI in patients with primary sclerosing cholangitis: inverse appearance of focal confluent fibrosis on delayed phase MR images with hepatocyte specific versus extracellular gadolinium based contrast agents. 
  • Contrast-Enhanced CISS Imaging for Evaluation of Neurovascular Compression in Trigeminal Neuralgia: Improved Correlation with Symptoms and Prediction of Surgical Outcomes. 
  • Contrast-enhanced hepatic magnetic resonance angiography at 3 T: does parallel imaging improve image quality? 
  • Contrast-enhanced magnetic resonance angiography: first-pass arterial enhancement as a function of gadolinium-chelate concentration, and the saline chaser volume and injection rate. 
  • Convection-enhanced delivery. 
  • Delayed magnetic resonance hepatic imaging with gadolinium-DTPA. 
  • Detection of infusate leakage in the brain using real-time imaging of convection-enhanced delivery. 
  • Diagnostic performance characteristics of architectural features revealed by high spatial-resolution MR imaging of the breast. 
  • Differential regulation of receptor-stimulated cyclic adenosine monophosphate production by polyvalent cations in MC3T3-E1 osteoblasts. 
  • Double spectral attenuated inversion recovery (DSPAIR)-an efficient fat suppression technique for late gadolinium enhancement at 3 tesla. 
  • Dual source hybrid spectral micro-CT using an energy-integrating and a photon-counting detector. 
  • Dynamic MR imaging of the biliary system using hepatocyte-specific contrast agents. 
  • Dynamic contrast-enhanced MR imaging assessment of vascularized free fibular grafts. 
  • Effects of myocardial water exchange on T1 enhancement during bolus administration of MR contrast agents. 
  • Effects of water exchange on the measurement of myocardial perfusion using paramagnetic contrast agents. 
  • Enhanced T2 contrast for MR histology of the mouse brain. 
  • Extravascular toxicity of two magnetic resonance contrast agents. Preliminary experience in the rat. 
  • Feature-Tracking Global Longitudinal Strain Predicts Death in a Multicenter Population of Patients With Ischemic and Nonischemic Dilated Cardiomyopathy Incremental to Ejection Fraction and Late Gadolinium Enhancement. 
  • Firategrast for relapsing remitting multiple sclerosis: a phase 2, randomised, double-blind, placebo-controlled trial. 
  • Following unenhanced MRI assessment for local recurrence after surgical resection of mesenchymal soft tissue tumors, do additional gadolinium-enhanced images change reader confidence or diagnosis? 
  • Formulation and characterisation of magnetic resonance imageable thermally sensitive liposomes for use with magnetic resonance-guided high intensity focused ultrasound. 
  • Four-dimensional MR microscopy of the mouse heart using radial acquisition and liposomal gadolinium contrast agent. 
  • Functional imaging of tumor vasculature using iodine and gadolinium-based nanoparticle contrast agents: a comparison of spectral micro-CT using energy integrating and photon counting detectors. 
  • Fundamentals of quantitative dynamic contrast-enhanced MR imaging. 
  • Gadofosveset-enhanced magnetic resonance angiography of the thoracic vasculature in the equilibrium phase: feasibility and impact of dose. 
  • Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy. 
  • Gadolinium chloride alters the acinar distribution of phagocytosis and balance between pro- and anti-inflammatory cytokines. 
  • Gadolinium enhancement of the leptomeninges caused by hydrocephalus: a potential mimic of leptomeningeal metastasis. 
  • Gadolinium-based contrast agents: A comprehensive risk assessment. 
  • Gadolinium-conjugated gold nanoshells for multimodal diagnostic imaging and photothermal cancer therapy. 
  • Gadopentetate-dimeglumine-enhanced MR imaging of gliomatosis cerebri: appearance mimicking leptomeningeal tumor dissemination. 
  • Gain in signal-to-noise for first-pass contrast-enhanced abdominal MR angiography at 3 Tesla over standard 1.5 Tesla: prediction with a computer model. 
  • Gd-DTPA-enhanced MR imaging of leptomeningeal spread of primary intracranial CNS tumor in children. 
  • Gold nanoparticles provide bright long-lasting vascular contrast for CT imaging. 
  • Group II GBCM Can Be Used Safely for Imaging in Stage 4/5 CKD Patients: CON. 
  • High-dose gadolinium-enhanced MRI for diagnosis of meningeal metastases. 
  • High-resolution magnetic resonance angiography in the mouse using a nanoparticle blood-pool contrast agent. 
  • Hybrid silica nanoparticles for multimodal imaging. 
  • ICAM-1 expression in autoimmune encephalitis visualized using magnetic resonance imaging. 
  • Imaging of Clinically Unrecognized Myocardial Fibrosis in Patients With Suspected Coronary Artery Disease. 
  • Imaging of convection enhanced delivery of toxins in humans. 
  • Impact of Stress Cardiac Magnetic Resonance Imaging on Clinical Care. 
  • Incidence of gadolinium or fluid signal within surgically proven glenoid labral tears at MR arthrography. 
  • Is Gadolinium contrast enhancement necessary in screening MRI for asymmetric sensorineural hearing loss? 
  • Kupffer cell depletion abolishes induction of interleukin-10 and permits sustained overexpression of tumor necrosis factor alpha messenger RNA in the regenerating rat liver. 
  • Kupffer cell depletion by gadolinium chloride enhances liver regeneration after partial hepatectomy in rats. 
  • LINAC based stereotactic radiosurgery for multiple brain metastases: guidance for clinical implementation. 
  • Late Gadolinium Enhancement and the Risk for Ventricular Arrhythmias or Sudden Death in Dilated Cardiomyopathy: Systematic Review and Meta-Analysis. 
  • Left Ventricular Noncompaction: Meglio solo che mal accompagnati: Italian proverb: "Better Alone Than in Bad Company". 
  • Liver metastases: improved detection with dynamic gadolinium-enhanced MR imaging? 
  • Long-Term Embolic Outcomes After Detection of Left Ventricular Thrombus by Late Gadolinium Enhancement Cardiovascular Magnetic Resonance Imaging: A Matched Cohort Study. 
  • Magnetic resonance arthrography of the shoulder: accuracy of gadolinium versus saline for rotator cuff and labral pathology. 
  • Magnetic resonance contrast agents for liver imaging. 
  • Magnetic resonance imaging for the assessment of myocardial viability. 
  • Magnetic resonance imaging in patients with central nervous system pathology: a comparison of OptiMARK (Gd-DTPA-BMEA) and Magnevist (Gd-DTPA). 
  • Magnetic resonance imaging of guinea pig cochlea after vasopressin-induced or surgically induced endolymphatic hydrops. 
  • Magnetic resonance imaging of the pancreas with gadolinium-DTPA. 
  • Methodology for the measurement and analysis of relaxation times in proton imaging. 
  • Multimodal optical and Gd-based nanoparticles for imaging in inflammatory arthritis. 
  • Myocardial Damage Detected by Late Gadolinium Enhancement Cardiac Magnetic Resonance Is Uncommon in Peripartum Cardiomyopathy. 
  • Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. 
  • Myocardial fibrosis detected with Gadolinium Delayed Enhancement in Cardiac Magnetic Resonance Imaging and Ventriculoarterial Coupling alterations in patients with Acute Myocarditis. 
  • NMR studies of combined lanthanide shift and relaxation agents for differential characterization of 23Na in a two-compartment model system. 
  • Nephrogenic systemic fibrosis is associated with hypophosphataemia: a case-control study. 
  • Nephrogenic systemic fibrosis: some considerations on the debate regarding its cause. 
  • Novel technique for characterizing prostate cancer utilizing MRI restriction spectrum imaging: proof of principle and initial clinical experience with extraprostatic extension. 
  • Outcomes at least 90 days since onset of myocarditis after mRNA COVID-19 vaccination in adolescents and young adults in the USA: a follow-up surveillance study. 
  • Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination. 
  • Perfusion MRI: the five most frequently asked technical questions. 
  • Phase III clinical evaluation of gadoteridol injection: experience in pediatric neuro-oncologic MR imaging. 
  • Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. 
  • Prevalence and distribution of late gadolinium enhancement in a large population of patients with Duchenne muscular dystrophy: effect of age and left ventricular systolic function. 
  • Prognostic Value of Stress CMR Perfusion Imaging in Patients With Reduced Left Ventricular Function. 
  • Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy. 
  • Prolonged Blood-Brain Barrier Disruption Following Laser Interstitial Ablation in Epilepsy: A Case Series with a Case Report of Postablation Optic Neuritis. 
  • Prostate diffusion imaging with distortion correction. 
  • Radiogenomic analysis of breast cancer: luminal B molecular subtype is associated with enhancement dynamics at MR imaging. 
  • Radiosurgical treatment for Ewing's sarcoma of the lumbar spine: case report. 
  • Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Potential mechanisms. 
  • Regulation of Kupffer cell TNF gene expression during experimental acute pancreatitis: the role of p38-MAPK, ERK1/2, SAPK/JNK, and NF-kappaB. 
  • Retrospective assessment of the utility of an iron-based agent for contrast-enhanced magnetic resonance venography in patients with endstage renal diseases. 
  • Right ventricular stress-induced perfusion defects and late gadolinium enhancement in coronary artery disease. 
  • Risk for Nephrogenic Systemic Fibrosis After Exposure to Newer Gadolinium Agents: A Systematic Review. 
  • Risk stratification using late gadolinium enhancement on cardiac magnetic resonance imaging in patients with hypertrophic cardiomyopathy: A systematic review and meta-analysis. 
  • Safety and diagnostic efficacy of gadoteridol for magnetic resonance imaging of the brain and spine in children 2 years of age and younger. 
  • Safety and technique of ferumoxytol administration for MRI. 
  • Sensing of extracellular cations in CasR-deficient osteoblasts. Evidence for a novel cation-sensing mechanism. 
  • Spectral diffusion: an algorithm for robust material decomposition of spectral CT data. 
  • Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols. 
  • Stress CMR in patients with obesity: insights from the Stress CMR Perfusion Imaging in the United States (SPINS) registry. 
  • Successful therapy for trilateral retinoblastoma. 
  • Suppression of ghost artifacts arising from long T1 species in segmented inversion-recovery imaging. 
  • T1 Mapping in Patients With Nonischemic Cardiomyopathy Undergoing Catheter Ablation: Moving Beyond Late Gadolinium Enhancement. 
  • Technique for MR imaging of the liver. 
  • The ability of the electrocardiogram in left bundle branch block to detect myocardial scar determined by cardiovascular magnetic resonance. 
  • The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. 
  • The use of gradient flow compensation to separate diffusion and microcirculatory flow in MRI. 
  • Transition metal-chelate complexes as relaxation modifiers in nuclear magnetic resonance. 
  • Utilizing 18F-fluoroethyltyrosine (FET) positron emission tomography (PET) to define suspected nonenhancing tumor for radiation therapy planning of glioblastoma. 
  • Validation of sub-segmental visual scoring for the quantification of ischemic and nonischemic myocardial fibrosis using late gadolinium enhancement MRI. 
  • Value of Late Gadolinium Enhancement Imaging in Diagnosis of Myocardial Infarction and Unobstructed Coronary Arteries. 
  • Venous filling defects on portal venous phase CT of the abdomen and pelvis: clinical implications and positive predictive value for diagnosing deep venous thrombosis. 
  • Verification of supraselective drug delivery for retinoblastoma using intra-arterial gadolinium. 
  • Verification of supraselective drug delivery for retinoblastoma using intra-arterial gadolinium. 
  • Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. 
• 

  Keywords of People

  • Johnson, G. Allan, Charles E. Putman University Distinguished Professor of Radiology, Biomedical Engineering